BUY REVENESSE ULTRA ONLINE ON MNV MEDICAL
See larger image

REVANESSE ULTRA

Reference - REVANESU
149.88 €

REVANESSE ULTRA 2x1 ml Syringes Revanesse Ultra is a dermal filler that can improve the appearance of facial wrinkles and creases, such as smile or laugh lines (nasolabial fold

Quantity : 
+
-
Product available

Add to cart

Ask an estimate

Share :
REVANESSE ULTRA

REVANESSE ULTRA

     

 

 

2x1 ml Syringes

 

Revanesse Ultra is a dermal filler that can improve the appearance of facial wrinkles and creases, such as smile or laugh lines (nasolabial folds)

Revanesse Ultra is a clear, colorless injectable gel that consists of crosslinked hyaluronic acid (HA) made by Streptococcus bacteria.

 

How does Revanesse Ultra work?

A doctor injects Revanesse Ultra into the facial tissue using an ultrafine needle.

Revanesse Ultra is used for patients older than 22 who want to improve the appearance of facial wrinkles folds,25 mg/ml moderately reticulated

 

What will it accomplish?

  • Revanesse Ultra may temporarily improve the appearance of the face by adding volume to lessen the visibility of moderate to severe facial wrinkles and folds.
When should it not be used?

Revanesse Ultra is not for patients who: are pregnant or breastfeeding, as the safety of these products for use during pregnancy, or in women who are breastfeeding, has not been studied have a history of hypertrophic scarring or keloid formation have evidence of scars at the intended treatment sites have acne and / or other inflammatory diseases of the skin, such as rosacea, seborrheic dermatitis, and psoriasis, have allergic history including; severe allergic reactions (anaphylaxis), heightened immune responses to common allergens, especially inhaled allergens and food allergens (atopy), allergy to natural rubber latex, allergy to hyaluronic acid products,

 

Streptococcal proteins or have plans to undergo administration of graded doses of allergens (desensitization therapy) during treatment with Revanesse Ultra. have acute or chronic skin disease, such as seborrheic dermatitis or rosacea, in or near the injection sites, or any infection or unhealed wound of the face are under concomitant anticoagulant therapy, antiplatelet therapy, or have a history of bleeding disorders, clotting disorders such as hemophilia or connective tissue disorders such as systemic lupus erythematosus

Back to top